MorphoSys AG American Depositary Shares
MOR was delisted on the 2nd of August, 2024.
56 hedge funds and large institutions have $207M invested in MorphoSys AG American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 20 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
21% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 14
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
4% more funds holding
Funds holding: 54 → 56 (+2)
13% less capital invested
Capital invested by funds: $236M → $207M (-$29.5M)
70% less call options, than puts
Call options by funds: $8.92M | Put options by funds: $29.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$21.4M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$18.8M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.3M |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
+$14.1M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$11.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$63.7M |
| 2 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$41.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$37.6M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$26.9M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$14.6M |
MOR Hedge Fund Activity: Q1 2024 in Review
56 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q1 2024, worth a combined $207M — down 13% from $236M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new MOR positions and 20 closed out — a net gain of 2 holders — while 17 added to existing stakes and 14 trimmed.
The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $21.4M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $63.7M sold.
- 56 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q1 2024, up from 54 in Q4 2023.
- Funds reported $207M of MorphoSys AG American Depositary Shares stock for Q1 2024, down 13% quarter-over-quarter.
- 22 funds opened new MorphoSys AG American Depositary Shares positions in Q1 2024 and 20 closed out, a net change of +2 holders.
- The largest MorphoSys AG American Depositary Shares buyer in Q1 2024 was Glazer Capital LLC, an estimated $21.4M added.
- The largest MorphoSys AG American Depositary Shares seller in Q1 2024 was T. Rowe Price Investment Management, an estimated $63.7M sold.
Based on aggregated 13F filings for Q1 2024.